EDEN PRAIRIE, Minn., June 12, 2023 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today its submission of a 510(k) application to the U.S. Food and…Read More
NeuroOne Submits 510k Application to FDA for OneRF Ablation System
